Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T14:55:57.229Z.
Calculation as of: 2026-10-06T14:55:57.229Z.
Quote observation: 2026-10-06T14:55:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d465a3cb364884174ea279f6e96e1b331d3038a7942601b23d7c9becb19c45da
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Avalyn Pharma Inc. Common Stock
Market Cap
$1.14B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12B
EV/FCF Ratio
10.36x
TTM Avg
12.48x
3Y Avg
15.43x
5Y Avg
19.92x
Market Cap
$1.12B
EV/FCF Ratio
252.57x
TTM Avg
136.50x
3Y Avg
244.79x
5Y Avg
184.87x
Market Cap
$1.16B
EV/FCF Ratio
9.59x
TTM Avg
11.64x
3Y Avg
21.94x
5Y Avg
33.17x
Market Cap
$1.09B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.09B
EV/FCF Ratio
41.25x
TTM Avg
63.43x
3Y Avg
61.39x
5Y Avg
58.90x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.14B | N/A | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.13B | N/A | N/A | N/A | N/A |
| OPKO Health, Inc. (OPK)vs › | $1.14B | N/A | 104.53x | 168.94x | 169.97x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 10.36x | 12.48x | 15.43x | 19.92x |
| Harrow Health, Inc. (HROW)vs › | $1.12B | 252.57x | 136.50x | 244.79x | 184.87x |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 9.59x | 11.64x | 21.94x | 33.17x |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.17B | N/A | 9.20x | 9.20x | 9.20x |
| IRadimed Corporation (IRMD)vs › | $1.09B | 41.25x | 63.43x | 61.39x | 58.90x |
| MannKind Corporation (MNKD)vs › | $1.20B | N/A | 74.41x | 125.98x | 125.98x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
